AlphaFold3 Reveals Protein Fold Redundancy for AI Drug Design
TL;DR. Deep learning models, including AlphaFold3, are improving biomolecular design despite significant redundancy in natural protein fold space. - Researchers found that scaling structural training data by folding more natural sequences does not add much new diversity. - The key challenge is converting vast genomic sequence data into useful 3D structural information for generative AI models. - Engineering tricks are necessary to extract genuinely diverse structural data beyond common protein folds.
- Deep neural networks enhance generative biomolecular modeling, impacting drug design.
- AlphaFold3's approach to scaling relies on converting sequence data to structural data, but faces redundancy.
- The diversity of protein folds is much narrower than the vast number of protein sequences suggests.
- Improving AI models for drug design requires more diverse structural training data, not just more sequences.
Sources
- The Unreasonable Redundancy of Nature's Protein Folds — research.ligo.bio